Q1: Subsequent Infusion

Question 1: Is this the report of a second or subsequent infusion for the same disease?

Indicate if this report is being completed for a second or subsequent infusion for the same disease.

Report No in the following scenarios:

• This is the first infusion reported to CIBMTR
• This is the first infusion given to treat the recipient’s current disease
• This is a second or subsequent infusion for the same disease and this baseline disease insert was not completed for the previous infusion (i.e., recipient was on TED track for the prior infusion, prior infusion was autologous with no consent, etc.)

Report Yes if this is a report of a second or subsequent infusion for the same disease and this CLL Pre-Infusion (2013) disease insert form was previously completed. If Yes, continue with the Pre-Infusion Therapy section.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.	.	.	.

Copyright © 2004-2024 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.